Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02507544 · ClinicalTrials.gov registry record · Phase 1

A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer

A Phase 1 study of Advanced Cancer and Carcinoma, sponsored by TaiRx.

Completed
Registry status
Phase 1
Development phase
36
Enrollment target
2
Study locations

NCT02507544 is a Phase 1 study of Advanced Cancer and Carcinoma that has completed, run by TaiRx. The registered enrollment target is 36 participants, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (85% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02507544, a Phase 1 study of Advanced Cancer and Carcinoma, has completed, sponsored by TaiRx.

COMPLETED
Registry status
Phase 1
Development phase
36 participants
Enrollment target
2
Study locations

Study Summary

TRX-818 is a new small molecule chemical entity being developed as a potential anti-cancer therapeutic by TaiRx, Inc. TRX-818 is a potent anti-cancer agent in numerous human cancer cell lines. The objectives of this study are to determine the safety profile of TRX-818 including identification of dose limiting toxicity (DLT) and maximum tolerated dose (MTD) and determine the recommended dose and regimen(s) to initiate Phase 2.

Conditions Studied

Advanced Cancer Carcinoma

Interventions

  • DRUG TRX-818 capsules

Study Locations (2)

Michigan

  • START Midwest - Grand Rapids

Texas

  • South Texas Accelerated Research Therapeutics, LLC (START) - San Antonio

Trial Details

FieldValue
Enrollment Target 36 participants
Start Date 2015-09
Est. Completion 2019-05-20
Phase Phase 1

Sponsor

TaiRx

2 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02507544

The ClinicalTrials.gov registry entry for NCT02507544 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 246-participant average among 122 other Advanced Cancer trials with a reported enrollment target (85% lower). The listed sponsor is TaiRx, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Advanced Cancer appearing as the primary indexed condition, and to 1 intervention - of which TRX-818 capsules is the first listed.

NCT02507544 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Michigan, Texas.

Frequently Asked Questions

What is clinical trial NCT02507544 about?

NCT02507544 is a clinical study titled "A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer". TRX-818 is a new small molecule chemical entity being developed as a potential anti-cancer therapeutic by TaiRx, Inc. TRX-818 is a potent anti-cancer agent in numerous human cancer cell lines. The objectives of this study are to determine the safety profile of TRX-818 including identification of dos...

What is the current status of trial NCT02507544?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 36 participants. The study started on 2015-09. Estimated completion is 2019-05-20.

What conditions does trial NCT02507544 study?

This clinical trial studies the following conditions: Advanced Cancer, Carcinoma.

What interventions are being tested in trial NCT02507544?

The interventions under investigation include: TRX-818 capsules (DRUG).

Who is sponsoring clinical trial NCT02507544?

This trial is sponsored by TaiRx, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02507544 being conducted?

This trial has 2 study locations across Michigan, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Advanced Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Advanced Cancer

All registered trials for this condition

Carcinoma

All registered trials for this condition

Michigan

All trials with a study site in Michigan

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.